Radiopharm Theranostics LimitedASX: RAD

RAD interim analysis at SNO26 on RAD101 Phase IIb data

· Issued by Radiopharm Theranostics Limited via ASX

Filed with ASX · · 3 pages · English

Release

ASX ANNOUNCEMENT 16 November 2026 Radiopharm Theranostics Presents Interim Analysis from Phase 2b Imaging Study of RAD101 in Suspected Recurrent Brain Metastases Following Radiotherapy at the Society for Neuro-Oncology Annual Meeting 18 Concordance between F-RAD101 PET and contrast-enhanced MRI...

Radiopharm Theranostics Limited on 6ix

Earlier from Radiopharm Theranostics

All Radiopharm Theranostics news releases